Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Radiant: PDT Inc. Is Shining a Light on New Drug Treatments




 

Investor's Business Daily (11/06/95) P. A4

New light-activated drugs are making a name for California- based PDT Inc. The drugs, which are selectively retained by diseased or cancerous cells, are activated by light, which produces a photochemical reaction in the targeted area. The new process combines drugs with medical devices to treat numerous diseases including AIDS-related Kaposi's sarcoma, skin cancer, heart disease, eye disorders, and urological conditions. PDT has so far signed deals with Pharmacia SpA, Cordis, and Boston Scientific, and several of its innovative drugs are in clinical and preclinical trials.



 


Copyright © 1995 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in November 7, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.